GAPDHP47

Across TCGA pan-cancer cohorts, GAPDHP47 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated GAPDHP47 data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher GAPDHP47 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated GAPDHP47 expression acts as an unfavorable survival marker, although some lineages such as CESC and LUSC show a favorable association.

KIRP, CESC, and THYM are the cancer types where GAPDHP47 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	OS	Tertile	All	0.881	0.973	<.001	97	view →
CESC	OS	Median	All	0.948	0.830	<.001	40	view →
THYM	OS	Quartile	III,IV	0.579	1.000	.008	38	view →
LUSC	OS	Median	All	0.735	0.611	<.001	34	view →
KIRC	OS	Quartile	All	0.523	0.668	.001	21	view →
LAML	DFS	Tertile	All	0.168	0.477	.013	18	view →
LUAD	DFS	Tertile	IV	0.342	0.893	<.001	18	view →
ACC	OS	Tertile	IV	0.327	0.633	.045	18	view →
THCA	DFS	Quartile	II,III,IV	0.608	0.856	.006	14	view →
PRAD	DFS	Quartile	All	0.909	0.722	.017	12	view →
HNSC	OS	Tertile	II,III,IV	0.443	0.658	.018	9	view →
LIHC	DFS	Tertile	III,IV	0.120	0.355	.002	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

GAPDHP47–KIRP (OS)

Open the KIRP breakdown →